The global Pet Antibiotic market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Pet antibiotics are medications prescribed by veterinarians to treat bacterial infections in various types of pets, including dogs, cats, and other animals. These antibiotics are similar to those used in humans but are specifically formulated and dosed for animals. Just like humans, pets can develop bacterial infections that can lead to various health issues if left untreated. Pet antibiotics help combat these infections and promote the well-being of the animals.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 496%.
publisher, Inc. (LPI) ' newest research report, the “Pet Antibiotic Industry Forecast” looks at past sales and reviews total world Pet Antibiotic sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Antibiotic sales for 2025 through 2031. With Pet Antibiotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Antibiotic industry.
This Insight Report provides a comprehensive analysis of the global Pet Antibiotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Antibiotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Antibiotic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Antibiotic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Antibiotic.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Antibiotic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral
Injection
Others
Segmentation by Application:
Dogs
Cats
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Elanco
Zoetis
Merck Animal Health
Merial
Bayer HealthCare
Boehringer Ingelheim GmbH
Ceva Santé Animale
Virbac Group
HealthforAnimals
Cymedica
Dechra
Jinhe Biotechnology
Orion Corporation
Phibro Animal Health Corporation
Vetoquinol
Virbac
Zydus
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet Antibiotic market?
What factors are driving Pet Antibiotic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Antibiotic market opportunities vary by end market size?
How does Pet Antibiotic break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Antibiotic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pet Antibiotic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pet Antibiotic by Country/Region, 2020, 2024 & 2031
2.2 Pet Antibiotic Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Others
2.3 Pet Antibiotic Sales by Type
2.3.1 Global Pet Antibiotic Sales Market Share by Type (2020-2025)
2.3.2 Global Pet Antibiotic Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pet Antibiotic Sale Price by Type (2020-2025)
2.4 Pet Antibiotic Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Others
2.5 Pet Antibiotic Sales by Application
2.5.1 Global Pet Antibiotic Sale Market Share by Application (2020-2025)
2.5.2 Global Pet Antibiotic Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pet Antibiotic Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pet Antibiotic Breakdown Data by Company
3.1.1 Global Pet Antibiotic Annual Sales by Company (2020-2025)
3.1.2 Global Pet Antibiotic Sales Market Share by Company (2020-2025)
3.2 Global Pet Antibiotic Annual Revenue by Company (2020-2025)
3.2.1 Global Pet Antibiotic Revenue by Company (2020-2025)
3.2.2 Global Pet Antibiotic Revenue Market Share by Company (2020-2025)
3.3 Global Pet Antibiotic Sale Price by Company
3.4 Key Manufacturers Pet Antibiotic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Antibiotic Product Location Distribution
3.4.2 Players Pet Antibiotic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pet Antibiotic by Geographic Region
4.1 World Historic Pet Antibiotic Market Size by Geographic Region (2020-2025)
4.1.1 Global Pet Antibiotic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pet Antibiotic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pet Antibiotic Market Size by Country/Region (2020-2025)
4.2.1 Global Pet Antibiotic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pet Antibiotic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pet Antibiotic Sales Growth
4.4 APAC Pet Antibiotic Sales Growth
4.5 Europe Pet Antibiotic Sales Growth
4.6 Middle East & Africa Pet Antibiotic Sales Growth
5 Americas
5.1 Americas Pet Antibiotic Sales by Country
5.1.1 Americas Pet Antibiotic Sales by Country (2020-2025)
5.1.2 Americas Pet Antibiotic Revenue by Country (2020-2025)
5.2 Americas Pet Antibiotic Sales by Type (2020-2025)
5.3 Americas Pet Antibiotic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Antibiotic Sales by Region
6.1.1 APAC Pet Antibiotic Sales by Region (2020-2025)
6.1.2 APAC Pet Antibiotic Revenue by Region (2020-2025)
6.2 APAC Pet Antibiotic Sales by Type (2020-2025)
6.3 APAC Pet Antibiotic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Antibiotic by Country
7.1.1 Europe Pet Antibiotic Sales by Country (2020-2025)
7.1.2 Europe Pet Antibiotic Revenue by Country (2020-2025)
7.2 Europe Pet Antibiotic Sales by Type (2020-2025)
7.3 Europe Pet Antibiotic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Antibiotic by Country
8.1.1 Middle East & Africa Pet Antibiotic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pet Antibiotic Revenue by Country (2020-2025)
8.2 Middle East & Africa Pet Antibiotic Sales by Type (2020-2025)
8.3 Middle East & Africa Pet Antibiotic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Antibiotic
10.3 Manufacturing Process Analysis of Pet Antibiotic
10.4 Industry Chain Structure of Pet Antibiotic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Antibiotic Distributors
11.3 Pet Antibiotic Customer
12 World Forecast Review for Pet Antibiotic by Geographic Region
12.1 Global Pet Antibiotic Market Size Forecast by Region
12.1.1 Global Pet Antibiotic Forecast by Region (2026-2031)
12.1.2 Global Pet Antibiotic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pet Antibiotic Forecast by Type (2026-2031)
12.7 Global Pet Antibiotic Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Elanco
13.1.1 Elanco Company Information
13.1.2 Elanco Pet Antibiotic Product Portfolios and Specifications
13.1.3 Elanco Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Elanco Main Business Overview
13.1.5 Elanco Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Pet Antibiotic Product Portfolios and Specifications
13.2.3 Zoetis Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Pet Antibiotic Product Portfolios and Specifications
13.3.3 Merck Animal Health Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Merial
13.4.1 Merial Company Information
13.4.2 Merial Pet Antibiotic Product Portfolios and Specifications
13.4.3 Merial Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merial Main Business Overview
13.4.5 Merial Latest Developments
13.5 Bayer HealthCare
13.5.1 Bayer HealthCare Company Information
13.5.2 Bayer HealthCare Pet Antibiotic Product Portfolios and Specifications
13.5.3 Bayer HealthCare Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer HealthCare Main Business Overview
13.5.5 Bayer HealthCare Latest Developments
13.6 Boehringer Ingelheim GmbH
13.6.1 Boehringer Ingelheim GmbH Company Information
13.6.2 Boehringer Ingelheim GmbH Pet Antibiotic Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim GmbH Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer Ingelheim GmbH Main Business Overview
13.6.5 Boehringer Ingelheim GmbH Latest Developments
13.7 Ceva Santé Animale
13.7.1 Ceva Santé Animale Company Information
13.7.2 Ceva Santé Animale Pet Antibiotic Product Portfolios and Specifications
13.7.3 Ceva Santé Animale Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ceva Santé Animale Main Business Overview
13.7.5 Ceva Santé Animale Latest Developments
13.8 Virbac Group
13.8.1 Virbac Group Company Information
13.8.2 Virbac Group Pet Antibiotic Product Portfolios and Specifications
13.8.3 Virbac Group Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Virbac Group Main Business Overview
13.8.5 Virbac Group Latest Developments
13.9 HealthforAnimals
13.9.1 HealthforAnimals Company Information
13.9.2 HealthforAnimals Pet Antibiotic Product Portfolios and Specifications
13.9.3 HealthforAnimals Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 HealthforAnimals Main Business Overview
13.9.5 HealthforAnimals Latest Developments
13.10 Cymedica
13.10.1 Cymedica Company Information
13.10.2 Cymedica Pet Antibiotic Product Portfolios and Specifications
13.10.3 Cymedica Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cymedica Main Business Overview
13.10.5 Cymedica Latest Developments
13.11 Dechra
13.11.1 Dechra Company Information
13.11.2 Dechra Pet Antibiotic Product Portfolios and Specifications
13.11.3 Dechra Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dechra Main Business Overview
13.11.5 Dechra Latest Developments
13.12 Jinhe Biotechnology
13.12.1 Jinhe Biotechnology Company Information
13.12.2 Jinhe Biotechnology Pet Antibiotic Product Portfolios and Specifications
13.12.3 Jinhe Biotechnology Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jinhe Biotechnology Main Business Overview
13.12.5 Jinhe Biotechnology Latest Developments
13.13 Orion Corporation
13.13.1 Orion Corporation Company Information
13.13.2 Orion Corporation Pet Antibiotic Product Portfolios and Specifications
13.13.3 Orion Corporation Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Orion Corporation Main Business Overview
13.13.5 Orion Corporation Latest Developments
13.14 Phibro Animal Health Corporation
13.14.1 Phibro Animal Health Corporation Company Information
13.14.2 Phibro Animal Health Corporation Pet Antibiotic Product Portfolios and Specifications
13.14.3 Phibro Animal Health Corporation Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Phibro Animal Health Corporation Main Business Overview
13.14.5 Phibro Animal Health Corporation Latest Developments
13.15 Vetoquinol
13.15.1 Vetoquinol Company Information
13.15.2 Vetoquinol Pet Antibiotic Product Portfolios and Specifications
13.15.3 Vetoquinol Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Vetoquinol Main Business Overview
13.15.5 Vetoquinol Latest Developments
13.16 Virbac
13.16.1 Virbac Company Information
13.16.2 Virbac Pet Antibiotic Product Portfolios and Specifications
13.16.3 Virbac Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Virbac Main Business Overview
13.16.5 Virbac Latest Developments
13.17 Zydus
13.17.1 Zydus Company Information
13.17.2 Zydus Pet Antibiotic Product Portfolios and Specifications
13.17.3 Zydus Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Zydus Main Business Overview
13.17.5 Zydus Latest Developments
14 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
